Growing Awareness of Amyotrophic Lateral Sclerosis (ALS) Around the World

September 1, 2014

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. It is a rapidly progressive and fatal neurological disease characterized by the gradual degeneration and death of motor neurons.

According to BCC Research reports, between one and two cases per 100,000 population appear every year; the disease commonly strikes people between 40 and 60 years of age, and men are slightly more prone to it than women. It has been estimated that there are 30,000 to 40,000 cases of ALS in the U.S. at any one time, and at least 200,000 in the developed world. Clearly, the global prevalence is much higher. Read the rest of this entry »


Automation in Clinical Diagnostics Can Help Minimize Non-Value-Added Processes

December 18, 2012

In a rapidly evolving field such as medical technology, terms such as new and emerging are clearly relative. Many diagnostic technologies have been introduced in the last few years, but new technologies are being introduced continually, superseding them.

With this fact in mind, this report pragmatically defines emerging diagnostic technologies as those that are only in limited commercial use and/or under development as of 2012. Technologies that are in the early stages of development, and in BCC’s judgment, unlikely to be commercialized before 2017 are not addressed in detail.

Also included are certain technologies, such as telemedicine, that have been in use for more than a few years, but which have the potential to cause a fundamental or paradigm shift in the way diagnoses are performed.

This report provides:

  • An overview of emerging diagnostic technologies, emphasizing the U.S. market in the context of efforts to rein in the cost of healthcare through improved diagnosis and early treatment
  • Analyses of market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Discussion of enabling techologies, including wireless, sensors, robotics, and artificial intelligence
  • A breakdown of end-user segments, such as hospitals, physician practices, home care, and military
  • Examinations of markets by type of technology and end-user groups
  • A focus on emerging MRI technologies, tomographic and nuclear medicine technologies, digital X-ray technologies, terahertz radiation, and hybrid technologies
  • Comprehensive company profiles of major players
  • Patent analysis.

 RSS Feeds – Healthcare

Use this report to:

  • Identifying the new diagnostic technologies with the greatest potential to influence the diagnostic market in the near to mid-term (2012-2017)
  • Analyzing the key drivers and constraints that will shape the market for these technologies over the next five years
  • Estimating the current and future demand for each of these technologies
  • Highlight the roles played by key players in the market.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.


Global population with diabetes expected to rise to 300 million people by 2025

December 4, 2012

This report provides:

  • An overview of the global market for diabetes therapies and diagnostics .
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Updates on merger and acquisition (M&A) activities.
  • Breakdowns of several national markets.
  • Information on research and development (R&D) trends.
  • Examination of healthcare policies, demographics, and the wider economic enviroment.
  • Comprehensive company profiles of major players in the relevant pharmaceutical and medical industries.

 RSS Feeds – Healthcare

 

Use this report to:

  • Forecast the market size for diabetes therapeutics and diagnostics in terms of dollar and unit sales.
  • Classify the market size for diabetes therapeutics and diagnostics by geographical regions in terms of dollar and unit sales.
  • Highlight the roles played by major stakeholders and players.
  • Examine crucial, innovative breakthroughs by means of a detailed patent analysis.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

 

Sales of anti-counterfeiting packaging technologies to reach $74.2bn by 2015

October 11, 2012

Global sales of anti-counterfeiting packaging technologies to the drug and food industries amounted to $59 billion in 2009. This figure is projected to reach $64 billion in 2010 and $74.2 billion by 2015, a compound annual growth rate (CAGR) of 3% from 2010 to 2015.

Learn about the applications of anti-counterfeiting packaging technologies in the global pharmaceutical and food industries. This report includes market projections (through 2015) of global sales of authentication and track and trace packaging technologies. Chapters on technology and patent analysis and company profiles are also included in this report…

Use this report to:

  • Understand the key factors that are projected to contribute to future sales of anti-counterfeiting packaging technologies to the global drug and food industries
  • Make informed business decisions about commercial opportunities in current and emerging anti-counterfeiting technologies, initiatives, and applications through 2015
  • Evaluate recent and foreseeable regulatory changes and their implications for brand owners, distributors, developers of secure technologies, and other stakeholders in global supply chain management
  • Develop competitive strategies to respond to increasing pressure to meet industry standards and develop technologies with enhanced security features and functionality in a timely and cost-efficient manner.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

RSS Feeds – Food and beverage

SUMMARY FIGURE
PROJECTED SHARES OF GLOBAL SALES OF ANTI-COUNTERFEITING PACKAGING TECHNOLOGIES TO THE DRUG AND FOOD INDUSTRIES BY TYPE, 2015
($ MILLIONS)

Source: BCC Research

Global market for congestive heart failure devices to grow to $5.9 billion by 2016

April 3, 2012

The global market for congestive heart failure devices was $3.1 billion in 2010. This market reached nearly $3.4 billion in 2011 and is expected to grow to $5.9 billion by 2016, a compound annual growth rate (CAGR) of 11.7%.

Learn about the devices to treat congestive heart failure and receive information on selected regions along with market revenue information for selected countries. Comprehensive company profiles are also covered

Use this report to:

  • Gain a comprehensive look at the devices for treating congestive heart failure (CHF)
  • Learn about current and future global markets, both the overall market and segmented markets
  • Understand the industry, its relationship to healthcare and its participants, and trends for the future
  • Analyze selected devices used to treat congestive heart failure from different standpoints and identify issues and trends affecting the CHF market.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

TOTAL GLOBAL MARKET FOR CONGESTIVE HEART FAILURE DEVICES, 2010-2016

($ MILLIONS)

TOTAL GLOBAL MARKET FOR CONGESTIVE HEART FAILURE DEVICES, 2010-2016

Source – BCC Research


Nanotechnology Medical Market Could Double Worth by 2013

September 26, 2008

In just five years, the global market for nanomedical technology could more than double its revenue to $3.8 billion. The market also has the potential to explode to $9.4 billion in 2018. These figures come from a study by BCC Research (Wellesley, MA).

The report, called Global Markets for Nanoscale Materials and Devices, separates the market into nano­particles, other nanostructure materials, and nanotools or nanodevices. In 2007, these applications generated $1.7 billion.¹

read more | digg story

¹Maria Fontanazza
Medical Device & Diagnostic Industry

Bookmark and Share


US market for stem cell technologies in next 5 years

August 12, 2008

According to a new technical market research report, STEM CELL TECHNOLOGY: CURRENT APPLICATIONS AND FUTURE DIRECTIONS (BIO035C) from BCC Research, the domestic market for stem cell technology is expected to increase from $112.0 million in 2007 to $423.1 million in 2012, a compound annual growth rate (CAGR) of 30.5%

The market is divided into cellular therapeutics and therapeutic banking categories. Stem cells in therapeutic banking have the larger share of the market, worth $65.9 million in 2007 and expected to increase to $155.7 million in 2012, for a CAGR of 18.8%.

Cellular therapeutics should be the faster growing segment. Cellular therapeutics generated $46.1 million in 2007 and is expected to generate $267.4 million in 2012, a CAGR of 42.1%.

read more | digg story

Bookmark and Share